BNP Paribas Financial Markets
RVLP

BNP Paribas Financial Markets’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

BNP Paribas Financial Markets’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2
Closed – – 4149
2023
Q3 		$0 Hold
2
– – ﹤0.01% 4068
2023
Q2 		$1 Sell
2
-5
-71% -$4 ﹤0.01% 3913
2023
Q1 		$8 Hold
7
– – ﹤0.01% 3821
2022
Q4 		$8 Hold
7
– – ﹤0.01% 4007
2022
Q3 		$15 Hold
7
– – ﹤0.01% 4701
2022
Q2 		$10 Sell
7
-100
-93% -$145 ﹤0.01% 4066
2022
Q1 		$181 Buy
+107
New +$153 ﹤0.01% 4081
2021
Q4 		– Sell
-43
Closed -$127 – 4285
2021
Q3 		$127 Sell
43
-4,304
-99% -$14.5K ﹤0.01% 3961
2021
Q2 		$13.1K Sell
4,347
-526
-11% -$1.61K ﹤0.01% 3656
2021
Q1 		$15.9K Buy
4,873
+1,132
+30% +$4.66K ﹤0.01% 3790
2020
Q4 		$15.4K Buy
3,741
+1,341
+56% +$7.73K ﹤0.01% 3884
2020
Q3 		$13K Buy
2,400
+1,987
+481% +$11.4K ﹤0.01% 3925
2020
Q2 		$2.78K Sell
413
-2,252
-85% -$11K ﹤0.01% 4149
2020
Q1 		$8.47K Buy
2,665
+1,626
+156% +$8.66K ﹤0.01% 4036
2019
Q4 		$7.26K Sell
1,039
-771
-43% -$4.12K ﹤0.01% 4156
2019
Q3 		$6.95K Buy
1,810
+6
+0.3% +$20 ﹤0.01% 4221
2019
Q2 		$6.86K Buy
+1,804
New +$6K ﹤0.01% 4187

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BNP Paribas Financial Markets's RVLP Position: Q4 2023 in Review

BNP Paribas Financial Markets sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 2 shares.

BNP Paribas Financial Markets first reported a position in RVLP in Q2 2019 and held it in 17 quarters. The position peaked at $15.9K in Q1 2021. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • BNP Paribas Financial Markets reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 2 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023.
  • BNP Paribas Financial Markets first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2019 and held it in 17 quarters.
  • BNP Paribas Financial Markets's RVL Pharmaceuticals plc Ordinary Shares position peaked at $15.9K in Q1 2021.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2023, filed 7 Feb 2024.